Blair Ford, MD

Academic Appointments

  • Professor of Neurology at CUMC

Current Administrative Positions

  • Director, Movement Disorders Surgery Center
Blair Ford, MD

Dr. Ford is a clinician, medical educator and clinical-investigator whose practice and research focuses on Parkinson's disease and movement disorders, including tremor, dystonia, Tourette syndrome, myoclonus, ataxia and chorea. Trained in Canada and the US in Internal Medicine and Neurology, he is board-certified in both specialties. His primary clinical work and research involves neuromodulation treatment using deep brain stimulation for Parkinson's disease, tremor and dystonia. He serves as Medical Director for the Center for Neuromodulation and Movement Disorder Surgery, a collaboration between the Departments of Neurology and Neurological Surgery at Columbia University that he co-founded in 1997.

As an educator, Dr. Ford has held the leadership position of the Department’s main educational programs – the Neurology Clerkship and the Neurology Residency Program; in this latter role, he served as the national Chair of Neurology Residency Program directors. Currently, Dr. Ford is Program Director for Columbia’s Movement disorders fellowship. An innovative teacher who makes extensive use of video, Dr. Ford has won numerous education, including Vagelos Columbia College of Physicians & Surgeons Bohmfalk Award, the medical school’s highest recognition for excellence in clinical teaching. He has won both of the Department of Neurology’s highest teaching awards, the Steven Shafer Award for humanism, and the Lewis P. Rowland Award for clinical excellence.

Dr. Ford has served as an examiner for the American Board of Psychiatry and Neurology. A Fellow of the American Academy of Neurology and a member of the American Neurological Association, Dr. Ford served for two terms on the Education Committee of the American Academy of Neurology (AAN). He has contributed over 100 original articles, reviews, and book chapters to the literature. Dr. Ford has lectured extensively on topics ranging from movement disorders, clinical neuroanatomy, neuromodulation to medical education. He has reviewed articles for Archives of Neurology, Movement Disorders, Neurology and the New England Journal of Medicine. Dr. Ford served as Scientific Editor for the Parkinson's Disease Foundation and has been listed as one of America's Best Doctors since 2002.

Departmental Appointments

  • Department of Neurology
    Division of Movement Disorders

Languages Spoken

(in addition to English)

  • French

Education and Training

  • McGill University Faculty of Medicine
  • MD Doctor of Medicine , 1985 Mc Gill University Faculty of Medicine
  • MD Doctor of Medicine , 1985 Mc Gill Univ Faculty Of Med
  • 1985 McGill University Medical School
  • Internship: 1988 Rhode Island Hospital
  • Residency: Rhode Island Hospital
  • Residency: 1988 Rhode Island Hospital
  • Residency: 1991 Mcgill University, Faculty of Medicine
  • Residency: 1991 McGill Univeristy / Faculty of Medicine
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: 1992 McGill Univeristy / Faculty of Medicine
  • Fellowship: 1992 Mcgill University, Faculty of Medicine
  • Fellowship: 1994 NewYork-Presbyterian / Columbia University Irving Medical Center
  • Fellowship: 1994 NewYork-Presbyterian/Columbia University Medical C

Centers / Institutes / Programs

  • Movement Disorders Surgery Center

Lab Locations

  • CUMC/Neurological Institute of New York

    710 West 168th Street
    350
    New York, NY 10032
    Phone:
    (212) 305-0549
    Fax:
    (212) 305-1304

Teaching Responsibilities

  • Director, Neurology Residency Program

Research Interests

  • Neurosurgical treatment using deep brain stimulati
  • Parkinson's disease and movement disorders

NIH Grants

  • A LONG-TERM FOLLOW-UP STUDY OF THE PATIENTS WHO UNDERWENT BILATERAL STIMULATION OF THE SUBTHALAMIC NUCLEUS (STN) USING THE LIBRA/LIBRAXP DEEP BRAIN STIMULATION SYSTEM AS AND ADJUNCTIVE TREATMENT (P&S Industry Clinical Trial)

    Aug 14 2013 - Aug 14 2018

    A PHASE 1/2 TRIAL ASSESSING THE SAFETY AND EFFICACY OF BILATERIAL INTRAPUTAMINAL AND INTERNIGRAL ADMIN OF CERE 120 (P&S Industry Clinical Trial)

    Nov 17 2010 - Nov 17 2015

    CLINICAL EVALUATION OF THE ANS TOTALLY IMPLANTABLE DEEP BRAIN STIMULATION SYSTEM FOR THE SUPRESSION OF TREMOR IN THE (P&S Industry Clinical Trial)

    Oct 13 2005 - Aug 31 2011

    HARLEM HOSPITAL AFFILIATION CONTRACT - GENERAL (NY Local Gov)

    Jul 1 2005 - Jun 30 2008